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ABSTRACT  Hille (1977.Journal of General Physiology. 69:497-515)  first proposed 
a  modulated  receptor hypothesis  (MRH)  to  explain the  action  of benzocaine  in 
voltage-gated  Na ÷  channels.  Using  the  MRH  as  a  framework,  we  examined 
benzocaine binding in batrachotoxin (BTX)-modified Na + channels under voltage- 
clamp  conditions  using  either  step  or  ramp  command  signals.  We  found  that 
benzocaine binding is strongly voltage dependent. At -70 mV, the concentration of 
benzocaine that inhibits 50% of BTX-modified Na ÷ currents in GHa cells (ICs0)  is 
0.2 raM, whereas at +50 mV, the IC~0 is 1.3 raM. Dose-response curves indicate that 
only one molecule of benzocaine is required to bind with one BTX-modified Na + 
channel at -70 mV, whereas approximately two molecules are needed at +50 inV. 
Upon treatment with the inactivation modifier chloramine-T, the binding affinity of 
benzocaine is reduced significantly at -70  mV, probably as a result of the removal 
of  the  inactivated  state  of  BTX-modified  Na  +  channels.  The  same  treatment, 
however, enhances  the binding affinity of cocaine near this voltage. External Na  + 
ions  appear  to  have  little effect on  benzocaine  binding,  although  they  do  affect 
cocaine  binding. We  conclude  that  two  mechanisms  underlie  the  action  of local 
anesthetics in BTX-modified Na  + channels.  Unlike open-channel blockers such as 
cocaine and bupivacaine, neutral benzocaine binds preferentially with BTX-modi- 
fled  Na ÷  channels  in  a  closed  state.  Furthermore,  benzocaine  can  be  modified 
chemically so that  it behaves like an  open-channel  blocker. This  compound  also 
elicits a use-dependent block in unmodified Na  + channels after repetitive depolar- 
izations, whereas benzocaine does not.  The  implications of these findings for the 
MRH theory will be discussed. 
INTRODUCTION 
Benzocaine  is  a  neutral  local  anesthetic  (LA)  that  contains  no  tertiary  amine 
component.  In  contrast,  other  clinical  LAs,  such  as  bupivacaine,  lidocaine,  and 
cocaine, possess a  tertiary amine that can be protonated at physiological pH (Ritchie 
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and Greene, 1985). The action of benzocaine and tertiary amine I.As on Na + currents 
and  gating  currents  has  been  extensively  studied  (for review,  see  Keynes,  1983; 
Butterworth and Strichartz, 1990; Hille, 1992). It has been suggested that benzocaine 
and  tertiary  amine  LAs  share  a  common  receptor  and  bind  more  strongly  with 
inactivated Na + channels than with their resting and open counterparts (Hille, 1977; 
1992).  This  hypothesis  is  generally  referred  to  as  Hille's  modulated  receptor 
hypothesis (MRH). 
Attempts to validate Hille's hypothesis have had mixed results. On the one hand, 
removal of Na + channel inactivation by pronase  treatment  appears  to reduce  the 
potency of the quaternary derivative of lidocaine, QX-314, on Na + currents, as would 
be predicted by the MRH theory (Cahalan,  1978; Yeh,  1978). On the other hand, the 
conflicting results  obtained  from  the  modification of Na +  channel  inactivation by 
s-scorpion toxin or by chloramine-T (CT) suggest that inactivation is not a prerequi- 
site for I~ action (Shepley, Strichartz, and Wang,  1983; Wang, Brodwick, Eaton, and 
Strichartz,  1987;  Ulbricht  and  Stoye-Herzog,  1984).  Thus,  whether  Na +  channel 
inactivation is directly involved in LA action remains an open question. 
Recently,  two  distinct  modes  of action  of LAs  in  batrachotoxin  (BTX)-modified 
Na +  channels  have been reported.  First,  tertiary amine  LAs,  such  as  cocaine and 
bupivacaine, have been found to be open-channel blockers; these LAs do not interact 
with  closed  BTX-modified  Na +  channels  (Wang,  1988;  Wang  and  Wang,  1992b). 
Second, preliminary results indicate that benzocaine binds to closed BTX-modified 
Na ÷  channels  and  interacts  less  effectively with  the  open  channel  (Moczydlowski 
Uehara, Guo, and Heiny, 1986; Wang and Wang,  1992a). A similar observation was 
reported by Ulbricht and  Stoye-Herzog (1984), who found that benzocaine cannot 
effectively block  veratridine-modified  Na +  channels  in  the  open  state  but  binds 
strongly to channels in their closed state. An unfortunate complication in studies of 
the action of benzocaine is  that the dose-response curve for benzocaine binding in 
unmodified  Na +  channels  cannot  be  fitted  by  the  Langmuir  isotherm.  At  an 
intermediate  dose  range  (0.25-1  raM),  the  binding  of one  benzocaine  molecule 
appears  to  block one  Na + channel,  whereas  at  a  high  dose  range  (1-2  raM)  two 
benzocaine molecules are probably needed (Meeder and Ulbricht,  1987; Elliott and 
Haydon,  1989). 
The purpose of this study was to examine benzocaine binding with BTX-modified 
Na +  channels  in  the  closed  and  open  states  using  the  whole-cell  patch  clamp 
technique. The planar lipid bilayer technique is not suitable for this purpose because, 
for reasons unknown to us, single BTX-modified Na + channels often disappear in the 
presence of benzocaine (Moczydlowski et al., 1986). Treatment with BTX allows us to 
distinguish the inactivated state of BTX-modified Na + channels in GH3 cells from the 
resting  and  open  states  (Wang  and  Wang,  1992a).  Without  BTX,  it  is  extremely 
difficult  to  study  inactivated  Na +  channels  because  they  rarely  reopen  during 
depolarization. The results of this  study led us  to suggest that  neutral benzocaine 
preferentially binds to BTX-modified Na + channels in a  closed form (probably the 
inactivated  state).  Furthermore,  we  also  found  that  it  is  possible  to  convert  the 
closed-channel blocker benzocaine into an open-channel blocker by simple structural 
modification. The ramifications of these findings for specific aspects of Hille's MRH 
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MATERIALS  AND  METHODS 
Chemicals 
Benzocaine (piCa =  2.54) was purchased from Sigma Chemical Co. (St. Louis, MO). N-dimethyl 
benzocaine (ethyl p-dimethylamino-benzoate)  was obtained from Pfaltz and Bauer, Inc. (Water- 
bury, CT). Both compounds were dissolved in dimethylsulfoxide at 500 mM and maintained as 
stock solutions at 4°C. CT was purchased from Aldrich Chemical Co. (Milwaukee, WI) and was 
dissolved in H20 at 40 mM before use. BTX and (-)-cocaine were provided by Dr. John Daly 
and Dr. Rao Rapaka (National Institutes of Health, Bethesda, MD), respectively. 
H  O  CH  s  0 
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Cell-Culture  and Whole-CeU Voltage Clamp 
Rat  pituitary  clonal  GH3  cells  were  maintained in  Dulbecco's  modified  Eagle's  medium 
supplemented with  10%  fetal  bovine serum  and  lX  glutamine as  described by  Cota  and 
Armstrong (1989).  The whole-cell variant of the patch-clamp method  (Hamill, Neher,  Sak- 
mann, and Sigworth,  1981)  was  used to measure Na  + currents in GHs cells.  Two external 
solutions were used; 0 Na  + solution, which contains (in mM) 150 choline'Cl, 0.2 CdCl2, 2 CaCl~, 
and  l0  HEPES  adjusted to  pH  7.4 with  tetramethyl hydroxide  (TMA-OH), and  150  Na  + 
solution, which contains 20 choline'C1,  130 NaCl, 0.2 CdCl2, 2 CaC12, and 10 HEPES adjusted 
to pH 7.4 with TMA-OH. 
Micropipettes were fabricated and had a tip resistance of ~ 1 Ml'l when filled with a high Na  + 
solution containing (in  mM):  0.005  BTX,  100  NaF,  30  NaCl,  10  EGTA,  and  10  HEPES 
adjusted to pH  7.2 with CsOH. The junction potential of electrodes was hulled before seal 
formation. Liquid junction potentials were measured to be 3.5  -+ 0.2 mV and 1.6  -+ 0.2 mV 
(n = 4) for 130 Na  + and 0 Na  + external solution, respectively,  and were not corrected in this 
report. After the rupture of the patch membrane, repetitive pulses (+50 mV with 50 ms at 2 
Hz;  Khodorov,  1978)  for  5-10  min,  converted  normal channels into  BTX-modified Na + 
channels (60-95%), as judged by the ratio of maintained (at 50 ms) and peak (at  ~ 1 ms) Na ÷ 
currents. Data acquisition and analysis were undertaken as described before (Wang and Wang, 
1992a).  Voltage-ramp protocols were created with pClamp software  (Axon Instruments, Inc., 
Foster City,  CA). BTX-modified Na + currents generated by this pulse protocol were  easily 
measurable. Leak and capacitance were subtracted by a  homemade device.  All experiments 
were performed at room temperature (23 +- 2°C). At the end of experiments, the drift in the 
junction potential was generally < 2 mV. Results of analyses are presented as mean _+ standard 
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RESULTS 
Only  One Benzocaine  Binding Site in the Inactivated BTX-modified Na ÷ Channel 
Previously, we suggested that  1 mM benzocaine strongly promotes the inactivation of 
BTX-modified Na + channels at a membrane potential near the resting potential (i.e., 
-70 mV) (Wang and Wang,  1992a). To determine the number ofbenzocaine binding 
site(s)  responsible  for the enhancement  of inactivation  of BTX-modified  Na + chan- 
nels, we examined the dose-response relationship.  Fig.  1 A shows BTX-modified Na + 
currents before and after treatment with various concentrations of benzocaine. After a 
5-s prepulse  to  -70  mV, the control BTX-modified Na + current exhibits  a  biphasic 
rising phase  during  a  test  pulse  of +50  mV,  as  has  previously been  reported.  The 
initial  rising  phase  (too  fast  to  be  recorded  at  this  time  scale)  was  interpreted  as 
representing  the  opening  of resting  BTX-modified  Na +  channels  and  the  second 
(slow) rising phase as representing  the reopening of inactivated  BTX-modified Na + 
channels  populated  during  the  -70  mV prepulse  (Epp).  Such a  reopening  process 
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FIGURE  1.  Inhibition  of BTX-modi- 
fled Na + currents by benzocaine. Na + 
channels were activated by a test pulse 
of +50 mV with a  prepulse  (Epp)  of 
-70 mV (A) or -170 mV (B) for 5 s. 
Current traces were superimposed for 
comparison.  Benzocaine (at  the con- 
centration  indicated) was  applied  for 
1-2  min  while  the  cell  was  held  at 
-100 mV. With an Epp of -70 mV, the biphasic rising phase of Na  + currents is present (A), 
whereas only a rapid rising phase, too fast to be recorded, is present with a prepulse of -  170 
mV (B). Na+currents recorded during an Epp of -70 mV were also inhibited by benzocaine in 
a concentration-dependent manner (A; front end of current traces). 
from normal inactivated Na + channels at  +50 mV occurs rarely,  if at all. Treatment 
with  benzocaine  not  only  slows  the  kinetics  of the  second  rising  phase  but  also 
progressively  reduces  the  amplitude  of the  first  rising  phase  in  a  concentration- 
dependent manner. On the assumption that the reduction of Na + currents in the first 
rising phase is due to direct binding of benzocaine during the Epp of -70  mV (Fig. 
1 A)  and  that  the  remaining  current  is  from  benzocaine-free  BTX-modified  Na + 
channels,  we constructed  a  dose-response  curve.  Fig.  2  (open  circle) shows  the  data 
obtained from seven separate  cells, which can be well fitted by a  Langmuir isotherm 
(solid line,  consistent with a  Hill coefficient value of 0.99 _+ 0.02).  The concentration 
that inhibits  50% of the initial  phase of the  Na + current  (ICs0) was estimated  to be 
207  +  12 ~M. This result suggests that at  -70  mV only one benzocaine molecule is 
needed to block one BTX-modified Na + channel. The action of benzocaine is readily 
reversible; superfusion of GHB cells with benzocaine-free solution reverses the effects 
of benzocaine on BTX-modified Na + channels within  1 min.  It is therefore unlikely 
that  the  inhibition  of currents  shown in  Fig.  1 A  is  due  to the  dissociation  of BTX 
from  its  binding  site  while  benzocaine  is  present.  If  BTX  dissociated  from  its 
receptor,  the  BTX-modified  Na  +  current would  not  reappear  after washing  unless WANG AND WANG  State-dependent Binding of Benzocaine in Na + Channels  505 
repetitive  pulses were reapplied  for the reassociation of BTX with the open state  of 
normal Na ÷ channels (Tanguy and Yeh,  1991). 
Deviation from  the One-to-One  Relationship for Benzocaine Block in BTX-modified 
Na + Channels  at  +50 mV 
Contrary to inactivated BTX-modified Na + channels, their resting and open counter- 
parts  do not appear to bind  to benzocaine effectively (Fig.  1 B). When resting  Na + 
channels  (at  -170  mV)  are  activated  by  a  strong  depolarizing  pulse  (+50  mV), 
benzocaine  elicits  a  time-dependent  block  that  is  concentration  dependent.  The 
degree  of block  at  the  end  of the  pulse  was  measured  and  plotted  against  the 
benzocaine concentration. Surprisingly,  the dose-response relationship  is not consis- 
tent with a  simple bimolecular interaction. The channel block by benzocaine is much 
too  steep  to  be  fitted  by a  Langmuir  isotherm  (Fig.  2,  dashed  line);  instead  a  Hill 
coefficient of 1.6  -  0.1  is observed  (Fig.  2, solid circles). The ICs0 is estimated  to be 
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FIGURE  '~.  Dose-response  curve  for 
benzocaine  inhibition  of BTX-modi- 
fled Na  + currents. The amplitudes of 
the fast  rising phase of Na  ÷ currents 
(shown in Fig.  1 A) at various benzo- 
caine  concentrations were  measured, 
normalized in relation to the control- 
current  amplitude,  and  plotted 
against the benzocaine concentration 
(open  circle) (n =  7).  The  solid  line 
represents the theoretical curve with a 
Hill coefficient of 1. The steady state 
currents maintained at the end of the 
test  pulse were  similarly  analyzed in 
Fig.  1 B  (solid circle) (n = 5).  Bar symbols represent  standard  errors.  In three  other experi- 
ments, steady state currents as shown in Fig.  1 B were also analyzed and yielded similar results. 
The solid line represents the theoretical curve with a Hill coefficient of 2, the dashed line with 
a coefficient of 1. 
1.3 -  0.1 mM. The solid line shown in Fig. 2 at +50 mV is the theoretical curve with 
a  Hill coefficient of 2.0. 
It  is  also  possible  to  measure  the  channel  block  at  +50  mV  from  the  re- 
equilibration  of the  benzocaine-bound  inactivated  Na ÷  channels.  The  unblock,  as 
indicated by a slowed rising phase (shown in Fig.  1 A ) suggests that benzocaine binds 
to the open BTX-modified Na ÷ channels with a lesser affÉnity than to the inactivated 
channels. The current amplitude at the end of the pulse was measured, normalized in 
relation  to  the  control  current  amplitude,  and  plotted  against  the  benzocaine 
concentration.  It should  be  noted  here  that  drug binding  to,  and  unbinding  from 
channels at + 50 mV nearly, but not completely, reach steady state during a 5- to 10-s 
pulse  as  shown  in  Fig.  1.  Unfortunately,  GH~  cells  rarely  survive  15-  to  30-s 
depolarizing  pulses  to  +50  mV.  The dose-response  curve obtained  by this  method 
yields  an  ICs0 value  of 1.1  --.  0.1  mM  and  a  Hill  coefficient  of  1.6  _+  0.1,  nearly 506  THE JOURNAL OF  GENERAL PHYSIOLOGY  • VOLUME 103"  1994 
identical to those shown in Fig. 2. Binding of benzocaine with resting BTX-modified 
channels at  -170  mV is extremely weak,  as indicated  by the small reduction of Na + 
currents at the beginning of the depolarization in Fig.  1 B (ICs0 >  3 mM). Because of 
the poor solubility of benzocaine at concentrations  higher than  3  mM,  no attempts 
were  made  to  fit  the  dose-response  curve  for  the  benzocaine  binding with  resting 
BTX-modified Na + channels. 
Voltage-dependent  Inhibition of BTX-modified Na + Currents  by Benzocaine 
In further  studies  of the voltage  dependence  of benzocaine  binding,  we applied  a 
voltage-ramp  protocol  ranging  from  -130  mV  to  +50  mV.  Fig.  3A  shows  BTX- 
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FIGURE 3.  Voltage  dependence  of benzocaine  binding  in  BTX-modified  Na  +  channels. 
BTX-modified Na + currents (A) were activated by a voltage-ramp protocol from -130 mV to 
+50 mV linearly for 15 s. The current trace was truncated from -130 to -100 mV where no 
Na  + currents were present.  Benzocaine (at  the concentrations indicated) was applied for 1-2 
min while  the  cell  was  held  at  -100  InV. The  degree  of block was  greater  at  the  resting 
membrane  potential  (-50  to  -90  mV)  than  at  positive  potentials  (0  to  +50  mV).  The 
amplitudes of Na  ÷ currents in (A) at various benzocaine concentrations at each voltage were 
measured,  normalized  in relation  to the control-current amplitude,  and  plotted  against  the 
voltage  (B).  Because  of the  relatively  small  current  amplitudes  below  -50  mV,  no reliable 
normalization can be obtained. Results  were similar in five other cells. 
modified currents under this voltage-ramp  protocol in the absence and presence of 
benzocaine at various concentrations. Without benzocaine, the BTX-modified current 
is normally activated between  -90  mV and  -80 mV, and the current amplitude then 
increases  continuously in a  nearly linear  manner.  The  shape  of the current-voltage 
ramp  relationship  is  essentially  the  same as  that of the current-voltage relationship 
measured  previously  by  step  depolarizations  (Wang  and  Wang,  1992a).  In  the 
presence  of benzocaine,  the  inhibition  of  BTX-modified  Na ÷  currents  is  clearly 
voltage  dependent  (but  see  Schneider  and  Dubois,  1986).  At  the  voltage  range WANG AND WANG  Slate-depertdent Binding of Benzocaine in Na + Channels  507 
around -90 to -60 mV of the current voltage-ramp curve, most currents are blocked 
by this range of benzocaine concentrations (0.3-3 mM), whereas at the more positive 
voltage potentials, the currents are inhibited less. 
This pulse protocol allows us to examine the apparent voltage-dependent binding 
visually from -50  to  +50  inV.  It is interesting that IC50 continues  to increase from 
0.3  mM at  -50  mV to  ~  1.2  mM at  +50 mV (Fig.  3 B). There is no sudden  switch 
from  a  high  binding  affinity  to  a  lower  affinity  within  this  voltage  range.  The 
dose-response  curve  at  +50  mV is  indistinguishable  to  that  measured  by voltage 
jump  experiments shown in Fig.  2.  The current-voltage ramp relationship  remains 
the  same when the duration  of voltage ramp is  15  s  (Fig.  3A)  or longer (i.e.,  1-2 
rain). This observation suggests that drug binding reaches its quasi steady-state (but 
not equilibrium) under this condition. 
Lack of Reduction of Benzocaine  Binding by External Na + Ions 
It is  commonly  known  that  external  Na +  ions  can  reduce  the  binding  affinity  of 
tertiary  and  quaternary  amine  LAs.  To  assess  whether  external  Na +  ions  affect 
neutral  benzocaine  binding,  we  raised  the  external  Na + ion  concentration  from 0 
mM to 130 mM. Fig. 4A shows that the inward Na + current is first activated around 
-90  to  -80  mV, reaches its peak,  and  then reverses (to outward)  near its reversal 
potential, 5.8  -+ 0.8 mV (n  =  14), which is slightly higher than the theoretical value of 
0  inV. The reason for this  ~ 6-mV depolarizing shift in the reversal potential is not 
clear" but may be due in part to the uncorrected liquid junctional  potential between 
internal and external solutions and the incomplete dialysis of cytoplasmic fluid with 
the  pipette  solution.  Inward  Na  +  currents  were  activated  near  -90  mV threshold 
voltage, which is  ~ 50 mV more negative than the activation threshold of normal Na  + 
currents  (Fig.  5).  In  the  presence  of benzocaine,  there  is  an  apparent  voltage- 
dependent shift of the peak current-voltage ramp relationship toward a more positive 
voltage direction  (Fig. 4  and 5). The inward  Na + current is now activated at larger 
depolarizations,  reaches  its peak at more positive potentials,  and  reverses near its 
reversal potential. The degree of block by benzocaine is again strongly dependent on 
the voltage applied (Fig. 4 B). The dose-response curve can be constructed with data 
from this type of experiment within the voltage range from -75 mV up to +50 mV. 
Fig. 6 shows that at -70 mV the data can be well fitted by a one-to-one relationship 
(with a  Hill coefficient of 0.97  +-- 0.02), whereas at  +50  mV they are again fitted by 
approximately a  two-to-one relationship  (with  a  Hill  coefficient of 1.6  +-_ 0.1).  The 
estimated  IC50 values at the  130  mM external  Na ÷ ion concentration  (0.14  _  0.01 
mM and  1.12  --- 0.01  mM at  -70  mV and  +50 mV, respectively) are slightly lower 
than those without external Na + ions (Fig. 2 and Fig. 3 B). Hence, external Na + ions 
do not reduce benzocaine binding. This result is in sharp contrast with the binding of 
tertiary and  quaternary  LAs with  Na ÷ channels  reported before in  squid  axons,  in 
lipid  bilayers,  and  in  cardiac  myocytes (Cahalan  and  Almers,  1979;  Wang,  1988; 
Barber,  Wendt,  Starmer,  and  Grant,  1992)  as  well  as  in  GH3  cells  (Wang,  G.K., 
unpublished observation). 
State-dependent  Binding of Benzocaine  in BTX-modified Na + Channels 
It  has  been  proposed  that  benzocaine  binds  preferentially  to  the  inactivated  Na + 
channels  (Hille,  1977;  1992).  How  does  one  demonstrate  that  this  hypothesis  is 508 
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FIGURE  4.  Effects  of  external  Na +  ions  on  benzocaine  binding  in  BTX-modified  Na ÷ 
channels.  Na +  currents were  activated  by  a  pulse  protocol  identical  to  that  in  Fig.  3 A.  The 
external  solution  contained  130  mM  of Na +  ions,  the  same  concentration  as  the  internal 
solution in the patch pipette. The  inward Na + current was activated at around  -85  mV (A). 
Benzocaine at various concentrations was applied for  1-2 min while the cell was held at  -  100 
mV. After benzocaine treatment the I/V  curve was shifted toward a  more positive direction and 
currents were  inhibited  in  a  voltage-dependent  manner.  Na +  current  amplitudes  at  various 
benzocaine  concentrations were  measured  at  voltages  from  -75  to  +50  mV,  normalized  in 
relation to the control-current amplitude, and plotted against voltage (B). Normalized currents 
near the reversal potential  (+6.8  mV) were truncated  because of difficulties in normalization 
due to their small amplitudes. 
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FIGURE  5.  Voltage  dependence  of 
! 
+BTX 
normalized  Na +  conductance  before 
(O)  and  after  (O)  BTX  treatment. 
Conductance  (g)  was  determined 
from  the  equation  g  =  Iya  (V-V,~v) 
where  INa  was  the current  amplitude 
under  voltage-ramp  conditions  (as 
shown  in  Fig.  4A)  or  the  peak  INa 
when no  BTX was present. The  con- 
ductance was normalized with respect 
to the maximal conductance and plot- 
-100'  -80  '  -60  " -40  " -20  '  6  '  2'0  "  4'0  '  ted  against  voltage.  The  solid  lines 
Membrane voltage (mV)  were a least-squares fit of the data and 
were drawn according to an equation: 
y  =  100/{1  +  exp [(Vo.5  -  V)/k]}  where the voltage for half-maximal activation,  V0.5, is  -64  -+ 
0.5  mV  (n =  5)  and  -14.6  _+  1.4  mV  (n =  4),  and  the  steepness factor,  k,  is  8.9  +  0.4  mV 
(n =  5)  and  7.6  -  0.5  mV (n =  4)  for BTX-modified and  normal  Na + channels,  respectively. 
Further  treatment  of  BTX-modified  Na +  channels  with  1  mM  benzocaine  (m;  i.e., 
+BTX  +  LA)  shifted  the  Vo.5  by  about  20  mV  toward  the  depolarizing  direction 
(Vo.5  =  -44.0  -+ 0.9 mV, n  =  4) and altered the steepness factor, k  =  12.8  _  0.8 mV (n =  4). WANG  AND  WANG  State-dependent Binding of Benzocaine in Na + Channels  509 
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FIGURE 6.  Voltage  dependence  of 
the dose-response curve at a  130 mM 
external  Na ÷ ion concentration.  The 
normalized  current  amplitudes  at 
-70  and  +50  mV,  as  shown  in  Fig. 
4 B  were  plotted  against  the  benzo- 
caine  concentration.  Data  were  ob- 
tained  from four separate cells.  The 
Hill coefficient for the dose-response 
curve was estimated to be 0.97 at -70 
mV  (the  solid  line  represents  the 
theoretical  curve  with  a  Hill  coeffi- 
cient  of 1)  and  1.6  at  +50  mV (the 
solid  line  represents  the  theoretical 
curve  with  a  Hill  coefficient  of  2, 
whereas the dashed line with a Hill coefficient of 1). Notice that the potency of benzocaine at 
high external Na + solution is similar to that without external Na + (Fig.  2). 
indeed  the mechanism for the action of benzocaine  in BTX-modified Na ÷ channels? 
To  address  this  question,  we  further applied  CT  to  remove  the  inactivation  of 
BTX-modified  Na  +  channels  (Wang  and Wang,  1992a).  Fig.  7  shows current  traces 
under  voltage  ramp  protocol  before  and  after  CT  treatment  for  5  min.  After  CT 
treatment,  BTX-modified  Na ÷ channels  are activated at more negative potentials  (a 
left-shift of 15  -+  1.4  mV, n  =  7), consistent with the findings  reported  previously in 
mammalian preparations  (Cukierman,  1991;  Niemann, Schmidtmayer, and Ulbricht, 
1991).  Current  amplitudes  also  increase  slightly  between  -50  and  +50  mV.  The 
degree of the current  increase varies from cell to cell perhaps  because CT-modified 
Na + channels (with an increase in the open probability) bind to BTX more efficiently 
than  unmodified  channels  (Tanguy  and  Yeh,  1991).  This  modification  of  the 
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FIGURE 7.  Modification  of  current- 
voltage ramp relationship by CT. Na + 
currents were generated by a standard 
voltage  ramp  protocol  identical  to 
that  described  in  Fig.  3A.  BTX- 
modified Na ÷ currents were measured 
before  and  after  treatment  with  0.5 
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current-voltage ramp curve by CT is irreversible,  even after continued superfusion of 
cells with drug-free solution. 
After  application  of CT  the  level  of benzocaine  binding  is  greatly  reduced  as 
measured from -75  mV to +50 mV (Fig. 8, C and D vs Fig. 8, A and B). Changes in 
the shape of the current-voltage ramp curve are also observed; benzocaine no longer 
binds  strongly at  the more negative potentials  (i.e.,  at  -50  mV; Fig.  8, B  vs D).  In 
fact, the reduction of binding at -50  mV is significantly greater than that at + 50 mV 
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FIGURE 8.  Reduction in benzocaine binding after treatment with CT. The effect of benzocaine 
(1 and 3 raM) on the current-voltage ramp relationship was measured before (A) and after (C) 
CT-treatment (0.5 mM, 5 min) with a standard voltage ramp protocol. Current amplitudes in 
the presence of benzocaine were normalized in relation to the control-current amplitude and 
plotted against voltage (B and D ). CT treatment reduces the binding affinity of benzocaine and 
changes the voltage dependence of this binding. Results were similar in seven other cells. 
(Fig. 8, B vs D). We were unable to construct dose-response curves of benzocaine in 
the CT-treated cells due to the reduced benzocaine affinity and the poor solubility of 
benzocaine.  Nevertheless,  our  result  provides  strong  evidence  that,  upon  binding, 
benzocaine enhances the inactivation of BTX-modified Na + channels. 
It is puzzling to observe the result shown in Fig. 8, because CT treatment does not 
affect benzocaine binding with unmodified  Na + channels in myelinated nerve fibers 
(Ulbricht  and  Stoye-Herzog,  1984;  Meeder  and  Ulbricht,  1987).  A  closer examina- WANG AND  WANG  State-dependent  Binding of Benzocame in Na ÷ Channels  511 
tion  of Fig.  8 C  at  the  voltage  range  between  -95  mV  and  -60  mV  shows  that 
benzocaine  still  blocks  BTX-modified  Na ÷  currents  substantially  more  than  at 
voltages  between  -50  and  +50  mV  (Fig.  8 D).  The  higher  benzocaine  affinity  at 
voltages between  -95  mV and  -60  mV could be due in part to incomplete removal 
of inactivation by CT and in part to a higher affinity of benzocaine toward the resting 
BTX-modified Na  + channels.  Because a  prolonged treatment with CT usually leads 
to membrane instability, we did not attempt to perform such an experiment. 
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FIGURE 9.  Effects  of CT treatment on cocaine binding.  Cocaine at 0.1  mM or 0.3 mM was 
applied before (A) and after (C)  treatment with 0.5 mM CT for 5 rain. A small reduction in 
cocaine binding was found after CT treatment (B) and (D) at voltages from 0 mV to +50 mV, 
whereas an increase in block was found from -50 mV to -25 mV. Results were similar in three 
other cells• 
Binding of Cocaine in BTX-modified Na + Channels Aider CT Treatment 
Because it can be argued that treatment with CT nonspecifically affects LA receptors 
in the  Na  + channel structure,  we repeated  the protocol in the  presence  of cocaine• 
We found that treatment with CT affects the binding of cocaine in a manner opposite 
to that seen with benzocaine  (Fig. 9). After CT treatment cocaine binding is  slightly 
enhanced from -50  mV to -30  mV (Fig. 9, B vs D), probably because this LA has a 512  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  103  •  1994 
greater probability of interacting with the open channels due to the left shift in the 
I/V  relationship.  Evidently,  cocaine  does  not  interact  well  with  inactivated  BTX- 
modified Na ÷ channels, because its binding is relatively weak at -50 mV, particularly 
in cells without CT treatment (Fig. 9 B). In addition,  the voltage-dependent binding 
of  cocaine  shows  a  pattern  that  is  the  opposite  of  that  seen  with  benzocaine. 
Inhibition of Na ÷ currents by cocaine under quasi steady state voltage-ramp condi- 
tions is significantly stronger at +50 mV than at -50 mV. There is a small reduction 
in binding  from 0  to  +50  mV after CT treatment  (Fig.  9 D),  but  this  reduction  is 
minimal compared with the reduction in benzocaine binding at  -50  mV (Fig.  8 D). 
Hence, treatment with CT results in a specific reduction of benzocaine binding but in 
little or no reduction of cocaine binding. 
Conversion of Benzocaine to a Different Mode of Action 
The  different  modes  of action  of benzocaine  and  cocaine  in  BTX-modified  Na + 
channels  raise  the  possibility  that  an  inactivation  enhancer  can  be converted  to  a 
blocker with a different state-dependent binding characteristic by modification of its 
Dimethyl Benzocaine (raM) 
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FIGURE 10.  Effects  of  N-dimethyl 
benzocaine  on  BTX-modified  Na ÷ 
currents.  N-dimethyl  benzocaine  at 
various concentrations was applied for 
1-2  rain  while  the  cell  was  held  at 
-100 inV. The external solution  con- 
tained no Na + ions. Step depolariza- 
tion  to  +50  mV (with a  prepulse of 
-170  mV)  activated  BTX-modified 
Na ÷ currents. N-dimethyl benzocaine 
elicited  a  time-dependent  block  that  was  concentration  dependent.  This  experiment  was 
repeated in four other cells, which yielded similar results. 
structure.  We  chose  several  benzocaine  derivatives  to  test  this  possibility.  Among 
them  were  ethyl  4-hydroxy  benzoate,  ethyl  3-hydroxy  benzoate,  tricaine,  methyl 
4-amino benzoate,  and N-dimethyl benzocaine.  One  of the  derivatives, N-dimethyl 
benzocaine,  failed  to  enhance  the  inactivation  of  BTX-modified  Na +  channels, 
whereas  the remaining drugs acted more or less as benzocaine.  Fig.  10 shows that 
N-dimethyl  benzocaine,  like  benzocaine,  produces  a  clear  time-dependent  block 
during a  +50-mV test pulse, a result suggesting that the resting channel binds poorly 
with this drug. We were unable to study the dose-response curve in detail, because we 
could  not  reliably  dissolve  N-dimethyl  benzocaine  at  3  mM  even  after  heating. 
However, N-dimethyl benzocaine appears to block BTX-modified Na  + channels in a 
different  voltage-dependent  manner  (Fig.  11 A)  from  that  of  benzocaine  under 
voltage-ramp conditions. The degree of block at various voltages was measured and 
plotted against voltage. Block of N-dimethyl benzocaine shows a voltage dependence 
that is reversed from (i.e., enhanced by depolarization) and weaker than the voltage 
dependence of benzocaine block. Hence, N-dimethyl benzocaine has no clear ability WANG AND WANG  State-dependent Binding of Benzocaine in Na ÷ Channels  513 
to  promote  the  inactivated  state  of  BTX-modified  Na +  channels  nor  to  block 
efficiently the resting state (Fig.  10). It is interesting that external Na  + ions also have 
no  effect  on  the  binding  of N-dimethyl  benzocaine;  the  blocking  effects  of this 
benzocaine derivative shown in Fig.  11 B are comparable to those seen at a  130-raM 
external Na  + concentration (data not shown). These results together suggest that it is 
possible  to  convert  benzocaine  to  a  different  state-dependent  blocker  by  simple 
structural modification and that external Na ÷ ions may not affect the binding of this 
converted blocker when the active form of the drug is not charged. 
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FIGURE 11.  Voltage  dependence  of 
N-dimethyl benzocaine binding.  Na  ÷ 
currents were activated by a standard 
vokage-ramp  pulse  protocol.  N-di- 
methyl benzocaine at  the concentra- 
tion  indicated  was  applied  for  1-2 
rain while  the cell was held  at  -100 
mV  (A). Current  amplitudes  with  1 
and  3  mM  dimethyl  benzocaine  at 
various voltages were measured,  nor- 
malized with  relation  to  the  control 
level, and plotted against voltage (B). 
The voltage-dependent binding of N- 
dimethyl benzocaine is different from 
that  of benzocaine  (Fig.  8 B).  The 
external  solution contained no NaCI. 
Use-dependent Block of N-Dimethyl Benzocaine  in  Unmodified Na + Channels 
It is unclear that the differences between benzocaine  and N-dimethyl benzocaine in 
blocking  BTX-modified  Na  +  channels  have  any  application  to  unmodified  Na ÷ 
channels.  Indeed,  BTX modifies most of Na  + channel properties  including channel 
gating,  ion selectivity,  as well as other ligand binding properties  (Khodorov,  1978). 
Therefore,  we  chose  to  examine  the  use-dependent  block  of  benzocaine  and 
N-dimethyl benzocaine  in unmodified  Na + channels  as a  possible  indicator  for the 
existence of different blocking mechanisms. 
Fig.  12A  shows that benzocaine  at  1 mM produces a  tonic block of normal  Na  + 
currents  but  fails  to  elicit  additional  use-dependent  block  when  stimulated  at  a 
frequency of 5 Hz (Fig.  12 C). In contrast, N-dimethyl benzocaine at  1 mM not only 514  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  103  •  1994 
produces a  tonic block (Fig.  12 B) but also elicits additional use-dependent block of 
Na +  currents  (Fig.  12 D).  Furthermore,  without  a  -130-mV  prepulse  (Fig.  12 C), 
Na  + current  amplitude  is  much smaller  than  that with  a  prepulse  (Fig.  12 A). This 
effect  is  due  to  a  left  shift  in  steady-state  inactivation  (1~)  of  ~ 20  mV  by  1  mM 
benzocaine  (also see Hille,  1977).  The left shift is much smaller by  1 mM dimethyl 
benzocaine (~ 10 mV). Clearly, N-dimethyl benzocaine and benzocaine behave quite 
differently in blocking normal as well as BTX-modified Na + channels. 
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FIGURE 12.  Use-dependent block of normal Na ÷ channels by N-dimethyl benzocaine. Normal 
Na  + channels in the absence of BTX were activated by a +30 mV depolarizing test pulse before 
and after treatment of I mM benzocaine (A) or 1 mM N-dimethyl benzocaine (B). The holding 
potential was -  100 mV, and the prepulse potential of -  130 mV for 50 ms was applied before 
the test pulse. Use-dependent block was further developed after repetitive test pulses (+30 mV 
for 25 ms at a frequency of 5 Hz) for N-dimethyl benzocaine (D) but not for benzocaine (C). 
Current traces were recorded every fifth pulse and superimposed for comparison. No prepulses 
were applied during repetitive test pulses. Leak and capacitance in (C) and (D) were subtracted 
partially by analog device.  The external solution contained no NaC1. 
DISCUSSION 
This study describes four new findings: (a) Only one benzocaine molecule is needed 
to enhance the inactivation of one BTX-modified Na ÷ channel. (b) External Na ÷ ions 
have  little  or  no  effect  on  benzocaine  binding.  (c)  Removal  of the  inactivation  of 
BTX-modified  Na ÷  channels  by  CT  drastically  reduces  their  binding  affinity  for 
benzocaine near  -70  mV.  (d) A  benzocaine derivative, N-dimethyl benzocaine,  fails 
to enhance the inactivation of BTX-modified Na + channels.  Block of BTX-modified 
Na  +  channels  by  N-dimethyl  benzocaine  exhibits  a  different  voltage  dependence 
from that of benzocaine.  Mso, N-dimethyl benzocaine,  but not benzocaine,  elicits  a 
use-dependent  block  in  unmodified  Na ÷  channels.  These  findings,  along with  the 
deviation from the one-to-one relationship of benzocaine binding with BTX-modified 
Na + channels at  +50 mV, will now be discussed  in detail. WANG AND WANG  State-dependent  Binding of Benzocaine in Na + Channels  515 
Interaction of Benzocaine with Inactivated BTX-modified Na + Channels 
Because  the dose-response curve for benzocaine at  -70  mV can be well fitted by a 
Langmuir isotherm with ICs0 that is lower than other voltages and because inactiva- 
tion is maximal around this potential (Wang and Wang,  1992a), we surmise that only 
one benzocaine molecule is needed to enhance the inactivation of one BTX-modified 
Na + channel. If so, then inactivation modifiers theoretically would reduce benzocaine 
binding.  This conjecture  is  strongly  supported  by the  fact that  treatment with  CT 
reduces  the  binding  affinity  of benzocaine  for  BTX-modified  Na  +  channels.  The 
effect of CT treatment on benzocaine binding at -70 mV appears to be specific. We 
do not find a drastic reduction of cocaine binding at -70 mV when we test the same 
CT-treated cell; in fact, cocaine binding is actually enhanced around this voltage (Fig. 
9). Removal of inactivation, therefore, has a much less pronounced effect on cocaine 
binding. 
Previously, Ulbricht and his coworkers (Ulbricht and Stoye-Herzog, 1984;  Meeder 
and Ulbricht,  1987) reported that benzocaine binding to unmodified  Na ÷ channels 
remains practically unchanged after 1 rain of CT treatment. Their results are clearly 
different from our finding in BTX-modified Na + channels shown in Fig. 8, B and D. 
However, we also noted that benzocaine still binds, although with a reduced affinity, 
around  -95  mV  to  -75  mV  more  strongly  than  around  -50  to  +50  mV  in 
BTX-modified Na + channels (Fig.  8 C).  It is possible that unmodified Na ÷ channels 
in their resting state and inactivated state have a similar affinity toward benzocaine. If 
so,  CT  treatment  may  produce  no  significant  changes  in  the  binding  affinity  of 
benzocaine in unmodified Na + channels. 
Two-to-One Stoichiometry  of Benzocaine Binding in BTX-modified Na + Channels 
at  +50 mV 
At +50 mV, BTX-modified Na  + channels display not only a weaker binding affinity 
for benzocaine but also a nonunity stoichiometry in binding with benzocaine (Figs. 4 
and 6). The simplest explanation for our dose-response curve is that at +50 mV two 
benzocaine  molecules  block  one  BTX-modified  Na ÷  channel.  If this  is  true,  an 
additional  benzocaine  binding  site  must  become  available  when  the  membrane 
voltage is switched to  +50  inV.  Both benzocaine binding  sites must be occupied if 
Na + permeability is to be inhibited. 
Alternatively, it is possible that a nonlinear relationship exists between the aqueous 
concentration  of benzocaine  and  the  effective concentration  near the  binding  site. 
(For a  discussion of this possibility, see Meeder and Ulbricht,  1987.) To explain the 
dose-response curve for BTX-modified Na + channels at +50 mV, one would need to 
postulate  that  the  effective  benzocaine  concentration  increases  more  than  the 
aqueous  benzocaine concentration  in  a  nonlinear manner.  Finally,  benzocaine  may 
cause membrane thickening (Elliott, Haydon, and Hendry, 1984; EUiott and Haydon, 
1989),  which  in  turn  may cause  an  abnormality in  benzocaine  binding with  BTX- 
modified channels. Unfortunately, these two alternatives do not explain why only one 
benzocaine  molecule  is  needed  to  block  BTX-modified  Na +  channels  at  -70  mV 
when tested at the same concentration range. 516  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  103  •  1994 
Structural Determinant  of Benzocaine  in the Enhancement of Inactivation 
How benzocaine enhances the inactivation of BTX-modified Na  + channels and why 
N-dimethyl  benzocaine  fails  to  do  so  are  important  questions  that  need  to  be 
addressed.  Because  N-dimethyl  benzocaine  does  not  enhance  the  inactivation  of 
BTX-modified Na + channels but does block open Na + channels,  a  simple explana- 
tion  for this  behavior is  that  the  4-amino  group  of benzocaine  is  involved  in  the 
enhancement of inactivation upon binding.  This 4-amino functional group is either 
dimethylated  as  in  N-dimethyl  benzocaine  or  not  present  as  in  (-)cocaine.  The 
interactions  between  the  4-amino  group  and  its  binding  site  could  stabilize  the 
inactivated state of BTX-modified Na + channels because they do not reopen readily 
(Fig.  1). One type of interaction may be through hydrogen bond(s) formed between 
the  4-amino  group  of  benzocaine  and  its  receptor.  Alternatively,  the  unshared 
electron of the 4-amino group may alter the resonance characteristic of the phenyl 
moiety, which  upon binding  may stabilize  the  receptor. These various possibilities 
may be addressed by detailed  studies of the structure-activity relationship of benzo- 
caine and its homologs. 
It  is  interesting  that  we  observed  no  effects  of  external  Na +  ions  on  neutral 
benzocaine or N-dimethyl benzocaine binding.  Many studies have suggested that the 
LA binding site is within the Na + permeation pathway, because external Na + ions can 
reduce  the  binding  affinity of tertiary  and  quaternary  LAs  (Cahalan  and  Almers, 
1979;  Wang,  1988;  Barber et  al.,  1991).  One  obvious explanation  for the  lack  of 
effect of Na +  ions  is  that  both  benzocaine and N-dimethyl benzocaine are  neutral 
compounds.  Hence,  no  charge  repulsion  between  Na +  ions  and  neutral  LAs  will 
develop even if they encounter each other within the permeation pathway. 
Implications for Hille's  MRH as a  Working Model 
Hille's MRH  for LA binding  in  unmodified  Na +  channels  consists  of two  general 
principles (Hille,  1977).  First,  there is one common binding site for all LAs. Second, 
this binding site changes its configuration in a state-dependent manner. HiUe further 
proposed that Na + channels in the inactivated state bind most strongly with I2ks. As a 
result,  such  a  conformation is  stabilized upon  binding.  The following discussion  is 
based on the MRH model as adapted for BTX-modified Na + channels. 
The  idea  of  a  common  binding  site  in  Na ÷  channels  for  all  LAs  remains 
controversial (for a review see Butterworth  and Strichartz,  1990).  If two benzocaine 
molecules are indeed needed to block one BTX-modified Na + channel at  +50 mV, 
then, by definition, two benzocaine binding sites must exist. Except in one case (Fig. 
2),  however,  all  LAs  in  our  studies  blocked  BTX-modified  Na +  channels  in  a 
one-to-one relationship (e.g., Wang and Wang,  1992b). At present, if we are to retain 
the one common binding site for all LAs as a working model, we are left with one last 
possibility:  that  the  common  LA binding  site  in  BTX-modified Na  +  channels  may 
accommodate two benzocaine molecules simultaneously at  + 50 mV. This possibility 
may be feasible, because  the  LA binding  site has been found  to contain  two large 
hydrophobic  binding  domains  (Wang,  1990).  Without  a  protonatable  amine,  the 
benzocaine molecule is unlikely to repel the  other even when they are adjacent  to 
each other. Our results, however, do not permit us to distinguish this possibility from WANG AND WANG  State-dependent  Binding of Benzocaine  in Na ÷ Channels  517 
the  two-site  theory.  Other  approaches,  such  as  competition experiments in single 
BTX-modified Na + channels or photoaffinity labeling and site-direct mutagenesis of 
cloned Na + channels may yield unequivocal evidence for one of these hypotheses. 
To  address  the  second component of Hille's MRH,  we  have  demonstrated  that 
benzocaine binding is indeed strongly state dependent. This state-dependent binding 
can be modified by the inactivation modifier CT. The specific feature of Hille's MRH 
that LAs bind most strongly with the inactivated form of Na  + channels, therefore, is 
consistent with benzocaine binding in BTX-modified Na + channels. However, this is 
not the case for open-channel blockers of BTX-modified Na + channels in planar lipid 
bilayers  or  in  GH3  cells  (Moczydlowski  et  al.,  1986;  Wang  and  Wang,  1992b). 
Evidently,  two  mechanisms  underlie  the  action  of  LAs  in  BTX-modified  Na ÷ 
channels. As  a  result,  LAs  may  bind preferentially with  the  closed  form  of BTX- 
modified Na ÷ channels (benzocaine) or with the open form (cocaine). In the future, 
different modes of LA action may also be uncovered in unmodified Na +  channels. 
The clear use-dependent block elicited only by N-dimethyl benzocaine in unmodified 
Na + channels but not by benzocaine may serve as a useful indicator to support such a 
conclusion. 
We are grateful  to  Drs. John Daly for providing us BTX, Bertil Hille for suggesting  experiments 
shown in Fig. 8, and Neil Castle for valuable comments. We thank Ms. Rachel Abrams for secretarial 
services and Ms. Jaylyn Oiivo for proofreading this manuscript. 
This work was supported by a grant from the National Institutes of Health (GM 35401 and 48090). 
Original version received 27 May 1993 and accepted version received 18 November 1993. 
REFERENCES 
Barber,  M. J.,  D. J.  Wendt,  C.  F. Starmer,  and A.  O.  Grant.  1992. Blockade of cardiac  sodium 
channels:  competition between  the permeant ion and antiarrhythmic  drugs. Journal  of Clinical 
Investzgation. 90:368-381. 
Butterworth, J. F., and G. R. Strichartz.  1990. Molecular mechanisms of local anesthetics: a review. 
Anesthesiology. 72:711-734. 
Cahalan, M. D. 1978. Local anesthetic block of sodium channels in normal and pronase-treated  squid 
giant axons. Biophysical  Journal.  23:285--311. 
Cahalan, M. D., and W. Almers. 1979. Interactions between quaternary lidocaine, the sodium channel 
gates and tetrodotoxin.  Biophysical  Journal.  27:39-56. 
Cota, G., and C. M. Armstrong.  1989. Sodium channel gating in clonal pituitary cells: the inactivation 
step is not voltage dependent.Journal of General Physiology. 94:213-232. 
Cukierman, S. 1991. Inactivation modifiers of Na + currents and the gating of rat brain Na + channels 
in planar lipid membranes. Pflugers Archiv.  419:514-521. 
Eiliott, J.  R.,  D. A. Haydon,  B.  M.  Hendry.  1984. The significance of the molecular  structure  of 
benzocaine  in relation to  its  suppression  of Na  current in  axons  of Loligo forbesi. Journal  of 
Physiology. 357:51P. 
Elliott, J.  R., and D. A. Haydon.  1989. The actions of neutral anesthetics on ion conductances  of 
nerve membranes. Biochimica et Biophysica Acta. 988:257-286. 
Hamill, O. P., M. E. Neher, B. Sakmann, and F. J. Sigworth. 1981. Improved patch-clamp techniques 
for high-resolution  current recording from cells and cell-free membrane patches. Pflugers Archiv. 
391:85-100. 518  THE JOURNAL OF  GENERAL PHYSIOLOGY • VOLUME 103"  1994 
Hille,  B.  1977.  Local  anesthetics:  hydrophilic  and  hydrophobic  pathways  for  the  drug  receptor 
reaction.Journal  of General Physiology. 69:497-515. 
Hille, B. 1992. Mechanisms of block. In Ionic channels of excitable membranes. Sinauer Associations, 
Sunderland, MA. 390-422. 
Khodorov, B.  1.  1978.  Chemicals as tools to study nerve fiber sodium channels: effect of batracho- 
toxin  and  some  local  anesthetics.  In  Membrane Transport  Processes.  Vol.  2.  D.  Tosteson,  Y. 
Ovchinnikov, and R. Latorre, editors. Raven Press, New York.  153-174. 
Keynes, R. D.  1983. Vohage-gated ion channels in the nerve membrane. Proceedings of the Royal Society 
London B Biological Sciences. 220:1-30. 
Meeder,  T.,  and  W.  Ulbricht.  1987.  Action  of benzocaine on  sodium  channels of frog  nodes  of 
Ranvier treated with chloramine-T. Pflugers Archiv. 409:265-273. 
Moczydlowski,  E.,  A.  Uehara,  X.  Guo,  and J.  Heiny.  1986.  Isochannels and  blocking  modes  of 
vohage-dependent sodium channels. Annals of the New York Academy of Sciences. 479:269-292. 
Nieman, P., J. Schmidtmayer, and W. Ulbricht. 1991. Chloramine-T effect on sodium conductance of 
neuroblastoma cells as  studied  by whole-cell clamp  and  single-channel analysis. Pflugers Archiv. 
418:129--136. 
Ritchie,  J.  M.,  and  N.  M.  Greene.  1985.  Local  anesthetics.  In  The  Pharmacological  Basis  of 
Therapeutics.  A.  G.  Gilman,  L.  S.  Goodman,  T.  W.  Rail,  and  F.  Murad,  editors.  MacMillan 
Publishing Co., New York. 302-321. 
Schneider,  M.  F.,  and J.  M.  Dubois.  1986.  Effects  of benzocaine on  the  kinetics of normal  and 
batrachotoxin-modified Na channels in frog node of Ranvier. Biophysical  Journal 50:523-530. 
Shepley,  M.  P.,  G.  R.  Strichartz, and G.  K. Wang.  1983.  Local anaesthetics block non-inactivating 
sodium channels in a use-dependent manner in amphibian myelinated axons.Journal  of Physiology. 
341:62P. 
Tanguy,  J.,  and  J.  z.  Yeh.  1991.  BTX-modification  of  Na  channels  in  squid  axons.  I.  State 
dependence of BTX action. Journal of General Physiology. 97:499-519. 
Ulbricht, W.,  and M.  Stoye-Herzog.  1984.  Distinctly different rates of benzocaine action on sodium 
channels of Ranvier nodes kept open by chloramine-T and veratridine. Pflugers Archiv. 402:439- 
445. 
Wang, G. K., M. S. Brodwick, D. C. Eaton, and G. R. Strichartz.  1987. Inhibition of sodimn currents 
by local anesthetics in chloramine-T treated squid axons. Journal of General Physiology. 89:645-667. 
Wang,  G.  K.  1988.  Cocaine-induced  closures  of single  batrachotoxin-activation Na +  channels in 
planar lipid bilayers. Journal of General Physiology. 92:747-765. 
Wang, G. K.  1990. Binding affinity and stereoselectivity of local anesthetics in single batrachotoxin- 
activated Na + channels. Journal of General Physiology. 96:1105-1127. 
Wang,  G.  K.,  and  S.  Y.  Wang.  1992a.  Inactivation of BTX-modified  Na + channels in  GH3  cells: 
characterization and pharmacological modification. Journal of General Physiology. 99:1-20. 
Wang, G. K., and S. Y. Wang.  1992b.  Altered stereoselectivity of cocaine and bupivacaine isomers in 
normal and BTX-modified Na + channels.Journal  of General Physiology. 100:1003-1020. 
Yeh, J.  z.  1978.  Sodium inactivation mechanism modulates  QA-314 block of sodium  channels in 
squid axons. Biophysical  JournaL  24:569-574. 